George Sflomos
@sflomos
I am a Cancer Researcher passionate about Lobular Carcinoma, Preclinical Oncology, Discovery Science & Advocacy @LobularBCA Member ECR Council @EACRnews
ID: 2401448066
https://people.epfl.ch/georgios.sflomos 21-03-2014 11:52:39
2,2K Tweet
1,1K Takipçi
1,1K Takip Edilen
ELBCC Modern Pathology Anne Vincent-Salomon Patrick WB Derksen COST #lobular breast cancer #ILC is NOT a rare subtype (=15% of all breast cancers!). Suboptimal inter-pathologist concordance has been repeatedly reported. See our ELBCC efforts to harmonise pathological diagnostic guidelines! Please apply in clinical practice and trials OncoAlert
Ένα βίντεο τρυφερό & πανέμορφο - Ύμνος στην δική του Ελλάδα, το Μεσολόγγι |Νίκος Αλιάγας eirinika.gr eirinika.gr/article/275024… via Ειρήνη Νικολοπούλου
Over 1,900 downloads in less than a week for our educational chapter on systemic therapy in #breastcancer. Thank you! Easy access here: ascopubs.org/doi/10.1200/ED… #teamwork #bcsm William Gradishar, MD Rebecca Shatsky, MD Hemali Batra-Sharma, MD UC San Diego Health Moores Cancer Center ASCO Journal of Clinical Oncology Dana-Farber’s Breast Oncology Center
Congrats to the team on our study showing long-term outcomes by lobular versus ductal histology in four large NSABP adjuvant breast cancer trials (B-22, B-25, B-28, B-30). Patients with ILC have elevated risk of late recurrence and death. academic.oup.com/jnci/article-a… UPMC Hillman Cancer Center
📌 Clinical management of oligometastatic cancer: Applying multidisciplinary tumor board recommendations in practice doi.org/10.1016/j.ctro… Matthias Guckenberger 👉🏻 generally high adherence to and implementation of MDT-recommended algorithms for OMD patients. 👉🏻 this study underscores the
Hot off the press! "Mechanisms of assembly and remodelling of the extracellular matrix" is now out in Nature Reviews Molecular Cell Biology doi.org/10.1038/s41580… It is a privilege to have been asked to review the current state of #ECM research and discuss exciting emerging research avenues, a 🧵: